Skip to main content
TipRanks
Go Ultimate75% OFF

Giant Biogene Holding Co. Ltd. (2367) Income Statement

11 Followers

Giant Biogene Holding Co. Ltd. Income Statement

Last quarter (Q2 2026), Giant Biogene Holding Co. Ltd.'s total revenue was ¥2.88B, an increase of 13.26% from the same quarter last year. In Q2, Giant Biogene Holding Co. Ltd.'s net income was ¥926.74M. See Giant Biogene Holding Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 5.52B¥ 5.54B¥ 3.52B¥ 2.36B¥ 1.55B
¥ 4.43B¥ 4.55B¥ 2.95B¥ 2.00B¥ 1.35B
¥ 2.31B¥ 2.24B¥ 1.28B¥ 817.32M¥ 425.62M
Depreciation and Amortization¥ 82.25M¥ 49.49M¥ 34.17M¥ 27.63M¥ 24.21M
¥ 2.20B¥ 2.33B¥ 1.78B¥ 1.21B¥ 934.78M
¥ 2.12B¥ 2.31B¥ 1.66B¥ 1.13B¥ 914.57M
¥ 229.52M¥ 149.12M¥ 80.22M¥ 44.61M¥ 62.34M
¥ 2.35B¥ 2.46B¥ 1.75B¥ 1.18B¥ 972.92M
¥ 1.91B¥ 2.06B¥ 1.45B¥ 1.00B¥ 828.13M
Per Share Metrics
Basic EPS¥ 1.83¥ 2.10¥ 1.49¥ 0.99¥ 0.84
Diluted EPS¥ 1.81¥ 2.06¥ 1.48¥ 0.98¥ 0.84
Weighted Average Shares Outstanding1.06B1.00B980.91M976.00M974.79M
Weighted Average Shares Outstanding (Diluted)1.06B1.00B982.72M1.02B991.61M

Currency in CNY

Giant Biogene Holding Co. Ltd. Earnings and Revenue History

02B4B6B30 %45 %60 %75 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin